Ranked by engagement
Top topics — all time page 15
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 15 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Pages past their review date, listed — does this still hold?
Asking directly, because I could not find a straight answer: Pages past their review date, listed — does this still hold? I have spent a fortnight trying to pin Pages past down and I want to set out where I…
|
+49 | 56 | 39k | 11d |
|
Revisiting: Absolute versus relative contraindications
Revisiting: Absolute versus relative contraindications — setting out what I have, and where I think it stops being reliable. A narrow question about Absolute versus relative contraindications, deliberately…
|
+80 | 85 | 7.4k | 3mo |
|
Comparators chosen for regulatory reasons rather than clinical ones — one year on
Comparators chosen for regulatory reasons rather than clinical ones — one year on — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Comparators chosen for…
|
+82 | 87 | 1.1k | 12mo |
|
[2026 update] Composite endpoints and the component doing the work
On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet , 2021) and…
|
+76 | 87 | 994 | 3mo |
|
[2026 update] Thyroid function tests during substantial weight change
Thyroid function tests during substantial weight change Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of Thyroid function tests during…
|
+69 | 74 | 4.5k | 2mo |
|
Why the timeline is on the right and not the left — what changed since
Why the timeline is on the right and not the left — what changed since I have a specific reason for asking rather than idle curiosity, and the context is below. What changes if the standard account of…
|
+77 | 81 | 4k | 2d |
|
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. A follow-up question about…
|
+73 | 79 | 2k | 4mo |
|
How to ask a question when you cannot say why you are asking it
Asking directly, because I could not find a straight answer: How to ask a question when you cannot say why you are asking it Question in the title. Context below, and I have tried to include the things people…
|
+49 | 53 | 36k | 4h |
|
Primary endpoint hierarchies and why order matters — one year on
On the subject in the title: Primary endpoint hierarchies and why order matters — one year on Working notes rather than a conclusion. A follow-up question about Primary endpoint hierarchies that I did not…
|
+56 | 61 | 37k | 11h |
|
Comparing my trajectory with the trial curves, carefully — a second dataset
Comparing my trajectory with the trial curves, carefully — a second dataset — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that…
|
+77 | 81 | 16k | 11h |
|
Packaging that arrived damaged: documenting it properly — a second dataset
Posting this under the heading it deserves: Packaging that arrived damaged: documenting it properly — a second dataset Everything below is what sits behind that. A logistics question, since the answers here…
|
+68 | 73 | 20k | 4mo |
|
Why mass spectrometry cannot tell you about an epimer
Why mass spectrometry cannot tell you about an epimer I have a specific reason for asking rather than idle curiosity, and the context is below. I have spent a fortnight trying to pin mass spectrometry down…
|
+75 | 82 | 4k | 17mo |
|
Revisiting: Liver enzymes drifting down and what that usually means
On the subject in the title: Revisiting: Liver enzymes drifting down and what that usually means Working notes rather than a conclusion. A methods question rather than a substantive one, about Liver enzymes…
|
+55 | 61 | 39k | 3h |
|
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
|
+74 | 80 | 17k | 2d |
|
Liver enzymes drifting down and what that usually means
Liver enzymes drifting down and what that usually means — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about liver enzymes drifting.…
|
+66 | 72 | 12k | 4mo |
|
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A question about how to describe something…
|
+80 | 86 | 5.6k | 3h |
|
Injection-site reactions: describing them precisely enough to be useful
Injection-site reactions: describing them precisely enough to be useful Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as evidence on…
|
+81 | 86 | 3.6k | 19mo |
|
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
|
+74 | 80 | 7.7k | 18mo |
|
Pinch or no pinch, and how needle length changes the answer — the long version
On the subject in the title: Pinch or no pinch, and how needle length changes the answer — the long version Working notes rather than a conclusion. A narrow question about Pinch, deliberately narrow, because…
|
+75 | 79 | 1.5k | 1mo |
|
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. Reading back through what has been written here about…
|
+63 | 68 | 35k | 1d |
|
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. Posting a small dataset on Prescription requirements and telehealth…
|
+87 | 94 | 1.1k | 21d |
|
A claim built entirely on a subgroup analysis
A claim built entirely on a subgroup analysis Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on claim built, and I…
|
+71 | 80 | 1.1k | 14mo |
|
Pinch or no pinch, and how needle length changes the answer — what changed since
Posting this under the heading it deserves: Pinch or no pinch, and how needle length changes the answer — what changed since Everything below is what sits behind that. What changes if the standard account of…
|
+58 | 62 | 16k | 1d |
|
Why catalogue breadth is not evidence of anything — what changed since
Asking directly, because I could not find a straight answer: Why catalogue breadth is not evidence of anything — what changed since What changes if the standard account of catalogue breadth is wrong? I ask…
|
+62 | 66 | 26k | 10mo |
|
Journal club: STEP 4 and what a withdrawal design can prove — one year on
Journal club: STEP 4 and what a withdrawal design can prove — one year on Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 4 ( JAMA , 2021). Please read…
|
+56 | 62 | 34k | 15mo |
|
Bug report: the reconstitution calculator and a rounding edge case
Bug report: the reconstitution calculator and a rounding edge case — setting out what I have, and where I think it stops being reliable. Posting the calculation with the inputs, so that somebody can disagree…
|
+68 | 72 | 28k | 4mo |
|
A revision dispute resolved on the topic rather than in the history — a second dataset
On the subject in the title: A revision dispute resolved on the topic rather than in the history — a second dataset Working notes rather than a conclusion. Posting a small dataset on revision dispute…
|
+45 | 50 | 33k | 20mo |
|
Journal club: the CagriSema phase 2 combination paper — a second dataset
Journal club: the CagriSema phase 2 combination paper — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on CagriSema phase 2 combination paper.…
|
+74 | 79 | 2.3k | 13mo |
|
Does a peptide degrade silently, with no visual change?
Does a peptide degrade silently, with no visual change? I have a specific reason for asking rather than idle curiosity, and the context is below. What changes if the standard account of peptide is wrong? I…
|
+73 | 79 | 1.3k | 1d |
|
Why the absence of controlled human data on BPC-157 matters more than people admit
Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to know what people…
|
+60 | 66 | 16k | 1d |